Literature DB >> 10984995

Role of vitamin E in rheumatic chorea.

M S Rawat1, A B Patel, A R Thete, C Bokde.   

Abstract

Rheumatic chorea is the sole neurologic manifestation of rheumatic fever. It is a debilitating illness lasting for weeks to months. Drugs like diazepam, haloperidol, chlorpromazine take four to six weeks for functional improvement and can cause serious side effects. The authors investigated the role of Vitamin E in reducing rheumatic chorea. A case series of patients of rheumatic chorea were administered Vitamin E in the dose 50 IU daily for fifteen days. The various clinical signs of rheumatic chorea were scored with MAIMS score (Modified Abnormal Involuntary Movement Scale score) which is used for tardive dyskinesia. No other drug for abnormal movements was used. In all the 4 patients who received vitamin E, there was remarkable change by 7th day and almost complete functional improvement by 14th day. Vitamin E is safer than the conventional drugs used for chorea in children. It was found effective in this case series. Its role needs further evaluation by a double-blind randomized controlled trial.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984995     DOI: 10.1007/BF02758479

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  13 in total

1.  Interrater reliability issues in multicenter trials, Part II: Statistical procedures used in Department of Veterans Affairs Cooperative Study #394.

Authors:  R Edson; P Lavori; K Tracy; L A Adler; J Rotrosen
Journal:  Psychopharmacol Bull       Date:  1997

Review 2.  Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

Authors:  J L Cadet; J B Lohr
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

Review 3.  The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illness.

Authors:  S Fahn
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

Review 4.  Vitamin E.

Authors:  M Meydani
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

5.  Oxy-radical toxicity in catecholamine neurons.

Authors:  G Cohen
Journal:  Neurotoxicology       Date:  1984       Impact factor: 4.294

6.  Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association.

Authors: 
Journal:  JAMA       Date:  1992-10-21       Impact factor: 56.272

7.  [Inhibition of the development of adjuvant arthritis in rats as affected by vitamin E].

Authors:  K D Pletsityĭ; E V Nikushkin; M A Askerov; L G Ponomarev
Journal:  Biull Eksp Biol Med       Date:  1987-01

8.  Reliability and validity of a tardive dyskinesia videotape rating technique.

Authors:  T R Barnes; T Trauer
Journal:  Br J Psychiatry       Date:  1982-05       Impact factor: 9.319

9.  Vitamin E supplementation suppresses prostaglandin E1(2) synthesis and enhances the immune response of aged mice.

Authors:  S N Meydani; M Meydani; C P Verdon; A A Shapiro; J B Blumberg; K C Hayes
Journal:  Mech Ageing Dev       Date:  1986-04       Impact factor: 5.432

10.  Hydroxyl radical attack on dopamine.

Authors:  A Slivka; G Cohen
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

View more
  1 in total

Review 1.  Treatment of Sydenham's Chorea: A Review of the Current Evidence.

Authors:  Shannon L Dean; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.